Medical devices, healthcare technology and the business of care
510(k) clearance · K250550

FUJIFILM Endoscope Model EG-S100XT and VS-1000 Display Unit

Fujifilm Corporation · Decision date Feb 17, 2026

FDA DECISIONK250550

What did the FDA decide?

FDA records K250550 as a 510(k) premarket notification, with a decision dated Feb 17, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Gastroenterology, Urology
Decision date
Feb 17, 2026

FDA source record

Regulatory record facts

Identifier
K250550
Regulatory pathway
510(k) premarket notification
Product code
FDS
Decision code
SESE
Decision date
Feb 17, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Gastroscope And Accessories, Flexible/Rigid.

Product code
FDS
FDA device class
2

FDA decision timeline

  1. K250550 received

    Application receipt date recorded by FDA.

  2. K250550 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code FDS

Product / regulatory recordCompanyPathwayDecision dateSource
Ambu A/S510(k) clearanceSep 16, 2026FDA
Olympus Medical Systems Corporation510(k) clearanceAug 27, 2026FDA
Olympus Medical Systems Corporation510(k) clearanceAug 27, 2026FDA
Intuitive Surgical, Inc.510(k) clearanceAug 7, 2026FDA
EvoEndo, Inc.510(k) clearanceApr 21, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Fujifilm Corporation

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Ashigara Kami-Gun

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records